Home News pCPA

05

Sep2023

pCPA Appoints Douglas Clark as its First CEO

On September 5, 2023, the pan-Canadian Pharmaceutical Alliance (pCPA) announced the appointment of Douglas Clark as its first CEO, effective September 11, 2023. Clark was Executive Director of the Patented Medicine Prices Review Board (PMPRB) for almost a decade before he resigned from that position earlier this year.... Read More

03

Aug2023

PCPA Seeks Stakeholder Input On Its Proposed Process To Implement CADTH Time-Limited Recommendations

The pan-Canadian Pharmaceutical Alliance (pCPA) introduced its proposed pCPA Temporary Access Process (pTAP) and invited stakeholders’ input on the process, its principles and conditions by August 18th, 2023.   The proposed pTAP and its associated principles are intended to inform pCPA negotiations and product listing agreements for ... Read More

13

Feb2023

 pCPA Recruiting Their First CEO

On February 3, 2023, pCPA Office announced a major step in its transition to a stand-alone organization: the recruitment of a chief executive officer (CEO). The new CEO is expected to be in place by Spring 2023. This announcement is a crucial part of the organizational review conducted in ... Read More

24

Feb2020

Status Summary of Innovative Medicine pCPA Negotiations as of January 31, 2020

Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your interest. Summary of New pCPA Activity Since ... Read More

10

Dec2019

Status Summary of Innovative Medicine pCPA Negotiations as of November 30, 2019

Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your interest.             ... Read More

22

Nov2019

Status Summary of Innovative Medicine pCPA Negotiations as of October 31, 2019

Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your interest. Summary of New pCPA Activity Since ... Read More

24

Oct2019

STATUS SUMMARY OF INNOVATIVE MEDICINE pCPA NEGOTIATIONS AS OF SEPTEMBER 30, 2019

Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your interest.  SUMMARY OF NEW PCPA ACTIVITY SINCE AUGUST ... Read More

12

Aug2019

Status Summary of Innovative Medicine pCPA Negotiations as of July 31, 2019

Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your interest. Summary of New pCPA Activity ... Read More

08

Jul2019

Status Summary of Innovative Medicine pCPA Negotiations as of June 30, 2019

Each month the pCPA issues an update on the previous month’s negotiation activity. Below you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your interest. Summary of New pCPA Activity Since Last Update Category New File... Read More

19

Jun2019

Status Summary of Innovative Medicine pCPA Negotiations as of May 31, 2019

Each month the pCPA issues an update on the previous month’s negotiation activity. In the summary below you will find an overview of the new pCPA activity along with PDCI insights into recent developments for your information. Summary of New pCPA Activity Since Last Update... Read More